Volume 1, Issue 11 pp. 1771-1784
Research Article

Total Synthesis and Biological Evaluation of a C(10)/C(12)-Phenylene-Bridged Analog of Epothilone D

Nicole End

Nicole End

Novartis Institutes for Biomedical Research, DA Oncology, CH-4002 Basel

Current address: Dr. Nicole End, Ciba Specialty Chemicals Inc., Group Research, K-420.2.18, CH-4002 Basel.

Search for more papers by this author
Pascal Furet

Pascal Furet

Novartis Institutes for Biomedical Research, DA Oncology, CH-4002 Basel

Search for more papers by this author
Nathalie van Campenhout

Nathalie van Campenhout

Novartis Institutes for Biomedical Research, DA Oncology, CH-4002 Basel

Search for more papers by this author
Markus Wartmann

Markus Wartmann

Novartis Institutes for Biomedical Research, DA Oncology, CH-4002 Basel

Search for more papers by this author
Karl-Heinz Altmann

Karl-Heinz Altmann

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH-Hönggerberg, HCI H405, CH-8093 Zürich (tel.: +41 44 633 73 90; fax: +41 44 633 13 60)

Search for more papers by this author
First published: 24 November 2004
Citations: 8

Abstract

The total synthesis of compound 8, a conformationally constrained analog of epothilone D (2), has been achieved through a convergent strategy based on three key fragments comprising C(1)C(6) (26), C(7)C(12) (16), and C(13)O(16) (19) of the macrocyclic framework. Construction of the C(12)C(13) bond involved Pd0-mediated B-alkyl Suzuki coupling between aryl bromide 16 and olefin 19, and proceeded in excellent yield, while formation of the C(6)C(7) bond through aldol reaction was somewhat less efficient. Surprisingly, macrolactonization was rather low-yielding and gave protected 8 only in 39% yield. Although 8 had been suggested by pharmacophore modeling to adopt a conformation similar to the bioactive conformation of epothilone B, the compound was devoid of any significant antiproliferative activity.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.